Home
2604-B23
2604-B23
Certificate of Analysis
Cagrilintide
Third-party analytical verification
Batch No.
2604-B23Purity
99.504%
Released
May 30, 2026
Batch Information
| Batch Number | 2604-B23 |
| Compound | Cagrilintide |
| Testing Laboratory | Kovera Labs |
| Analysis Method | RP-HPLC |
| Purity | 99.504% |
| Release Date | May 30, 2026 |
PDF Document
| PDF Filename | LyosLabs_CGL5_COA.pdf |
| PDF Uploaded | June 14, 2026 |
| PDF Size | 1.4 MB |
| PDF Status | Uploaded |
Analysis Results
| HPLC Purity | 99.504% |
| Purity Specification | >98% |
| Net Content | 5.34 mg |
| Net Content Specification | ~5 mg |
| Molecular Formula | C194H312N54O59S2 |
| CAS Number | 1415456-99-3 |
| Identity Confirmation (LC-MS) | Cagrilintide |
| Physical Form | Lyophilized powder |
| Analytical Method | RP-HPLC | C18 | DAD @ 214 nm |
| Report Number | KVR-2026-82CC02 |
| Verification Code | TW2YVIH |
Research Use Only
This certificate confirms analytical testing results for research-grade material. All products are supplied exclusively for in vitro research and preclinical studies. Not for human consumption or clinical use. Lyos Labs assumes full compliance by the purchaser with applicable local and federal regulations.